There are errors in the "Oncomine data analysis" section of the Materials and Methods. It should read:

Oncomine and CCLE data analysis

We used the Oncomine Cancer Genomics Data Analysis tool \[30\] and Cancer Cell Line Encyclopedia, CCLE \[35\] to mine *Usmg5* copy number profiles in a large subset of cancer cell lines \[31, 34, 35, 38, 41, 65--69\]. In the dataset, the log2 (≥ 0,34) values were analyzed. The number of DNA copies (= 2\*(2\^y-axis value)) were calculated as advised in Oncomine instructions.

There are errors in the "*Usmg5* copy number in cancers" section of the Results. It should read:

*Usmg5* copy number in cancer cell lines

Since DAPIT over-expression induced EMT and glycolytic switch in HEK293T cells, we tested if DAPIT is over-presented in cancer cell lines. The Oncomine Cancer Genomics database and CCLE revealed a duplication (3--4 copies) of *Usmg5* copy number in a large panel of cell lines ([Table 2](#pone.0141036.t001){ref-type="table"}) Several datasets indicated uniform increase in copy number in various lung (NCI-H1775, NCI-H1993, NCI-H1563, NCI-H1755, VMRC-LCD, SBC-5, NCI-H1703), gastric (HCT116, Hs746T, MKN74, SNU-668), ovarian (OVTOKO, MCAS), liver (SNU-398) and pancreatic (PSN1, PANC-1) cancer cell lines. The copy number was also confirmed in breast (SUM-52PE), endometrial (AN3CA), esophagus (OE33), hematopoietic (MPLM6), kidney (SNU-1272) and lymphoid (Ki-JK) cell lines, being encountered once in the others. These data strongly suggest a role for DAPIT over-expression in cancers.

10.1371/journal.pone.0141036.t001

###### Cancer cell lines expressing increased genomic *Usmg5* copy number in Oncomine cancer genomics database and Cancer Cell Line Encyclopedia, CCLE.
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Classification                                         Cancer type                       Cell line                      DNA copy number                 Oncomine dataset/ CCLE
  ------------------------------------------------------ --------------------------------- ------------------------------ ------------------------------- -----------------------------
  Bone                                                   Osteosarcoma                      143B                           2,76                            CCLE \[31\]

  Brain                                                  Brain gioblastoma                 A-172                          3,48                            Berouchim brain \[35\]

  Cerebral glioblastoma                                  LN-18                             2,78                           Berouchim brain \[35\]          

  Breast                                                 Breast adenocarcinoma             MCF7                           2,62                            Nicolsky Breast \[32\]

  Breast carcinoma                                       SUM-52PE                          3,60\                          Nicolsky Breast \[32\]\         
                                                                                           3,42                           Chin breast2 \[65\]             

  CAL-51                                                 3,28                              Hu CellLine2 \[66\]                                            

  MDA-MB-468                                             2,96                              Hu CellLine2 \[66\]                                            

  CAL-120                                                2,81                              Hu CellLine2 \[66\]                                            

  Hs 578T                                                2,74                              Hu CellLine2 \[66\]                                            

  MDA-MB-361                                             2,72                              Hu CellLine2 \[66\]                                            

  HCC1806                                                2,62                              CCLE \[31\]                                                    

  Ductal breast carcinoma                                T-47D                             3,18                           Nicolsky Breast \[32\]          

  MFM-223                                                2,85                              Nicolsky Breast \[32\]                                         

  Squamous cell breast carcinoma, Acantholytic variant   HCC1806                           2,88                           Hu CellLine2 \[66\]             

  Central nervous system                                 Cannabinoid receptor              CB1                            2,69                            CCLE \[31\]

  Glioma                                                 KSN60                             2,59                           CCLE \[31\]                     

  Endometrium                                            Endometrial adenocarcinoma        JHUEM2                         2,60                            CCLE \[31\]

  AN3CA                                                  2,60\                             CCLE \[31\]\                                                   
                                                         2,59                              Rothenberg CellLine \[38\]                                     

  Esophagus                                              Eesophageal adenocarcinoma        JHESOAD1                       2,61                            CCLE \[31\]

  Barrett\'s adenocarcinoma                              OE33                              2,77\                          CCLE \[31\]\                    
                                                                                           2,65                           Wooster CellLine \[N/A\]        

  Gallbladder                                            Biliary tract cancer              SNU478                         3,49                            CCLE \[31\]

  Gastric                                                Cecum adenocarcinoma              LS411N                         2,70                            Lu colorectal \[67\]

  NCI-H498                                               2,61                              Lu colorectal \[67\]                                           

  NCI-H747                                               2,60                              Lu colorectal \[67\]                                           

  Colon adenocarcinoma                                   SW620                             2,88                           Lu colorectal \[67\]            

  HCT-15                                                 2,77                              Lu colorectal \[67\]                                           

  LS180                                                  2,72                              Lu colorectal \[67\]                                           

  Colon carcinoma                                        HCT116                            2,94\                          CCLE \[31\]\                    
                                                                                           2,78\                          Berouchim multicancer \[34\]\   
                                                                                           2,78\                          Lu colorectal \[67\]\           
                                                                                           2,77                           Rothenberg CellLine \[38\]      

  Gastric cancer                                         Hs 746T                           3,54\                          Rothenberg CellLine \[38\]\     
                                                                                           2,90                           Palanisamy gastric \[N/A\]      

  NCI-N87                                                3,41                              Palanisamy gastric \[N/A\]                                     

  KATO111                                                3,34                              Palanisamy gastric \[N/A\]                                     

  YCC-16                                                 3,21                              Palanisamy gastric \[N/A\]                                     

  HUG1N                                                  3,02                              CCLE \[31\]                                                    

  YCC-9                                                  3,00                              Palanisamy gastric \[N/A\]                                     

  YCC-6                                                  2,85                              Palanisamy gastric \[N/A\]                                     

  SNU520                                                 2,69                              CCLE \[31\]                                                    

  Gastric tubular adenocarcinoma                         MKN74                             2,74\                          CCLE \[31\]\                    
                                                                                           2,57                           Rothenberg CellLine \[38\]      

  Gastrointestinal stromal tumor                         GIST 882X                         2,97                           Berouchim multicancer \[34\]    

  Signet ring cell gastric adenocarcinoma                SNU-668                           2,93\                          CCLE \[31\]\                    
                                                                                           2,80                           Barretina CellLine 2 \[31\]     

  Hematopoietic tissue                                   Acute Myeloid Leukemia            CMK115                         2,90                            CCLE \[31\]

  KASUMI1                                                2,85                              CCLE \[31\]                                                    

  CMK                                                    2,67                              CCLE \[31\]                                                    

  M2-type of Myeloid Leukemia                            KASUMI6                           2,78                           CCLE \[31\]                     

  Blast phase cronic myelogenous leukemia                MOLM6                             2,78\                          CCLE \[31\]\                    
                                                                                           2,60                           Barretina CellLine 2 \[31\]     

  Chronic myeloid leukemia                               BV173                             2,55                           CCLE \[31\]                     

  Leukemia                                               NCO2                              2,53                           CCLE \[31\]                     

  Erythroleukemia                                        TF-1                              2,60                           Barretina CellLine 2 \[31\]     

  Kidney                                                 Clear cell renal carcinoma        SNU-1272                       3,13\                           CCLE \[31\]\
                                                                                                                          2,77                            Barretina CellLine 2 \[31\]

  Renal carcinoma                                        UOK101                            2,87                           CCLE \[31\]                     

  Human proximal tubular cell line, immortalized         HK2                               2,67                           CCLE \[31\]                     

  Renal adenocarcinoma                                   ACHN                              2,55                           CCLE \[31\]                     

  Liver                                                  Hepatocellular adenocarcinoma     SNU-398                        2,84\                           CCLE \[31\]\
                                                                                                                          2,75\                           Rothenberg CellLine \[38\]\
                                                                                                                          2,72\                           Wooster CellLine \[N/A\]\
                                                                                                                          2,59                            Barretina CellLine 2 \[31\]

  Hepatocellular carcinoma                               LI7                               3,40                           CCLE \[31\]                     

  C3A                                                    2,62                              CCLE \[31\]                                                    

  Lung                                                   Lung adenocarcinoma               NCI-HI435                      3,15                            CCLE \[31\]

  NCI-H1775                                              2,73\                             CCLE \[31\]\                                                   
                                                         2,62                              Lu lung \[67\]                                                 

  NCI-H1993                                              2,79\                             Lu lung \[67\]\                                                
                                                         2,72\                             Sos CellLine \[69\]\                                           
                                                         2,62                              Wooster CellLine \[N/A\]                                       

  NCI-H1563                                              2,74\                             CCLE \[31\]\                                                   
                                                         2,68                              Lu lung \[67\]                                                 

  NCI-H1838                                              2,63                              Lu lung \[67\]                                                 

  NCI-H1755                                              2,86\                             Sos CellLine \[69\]\                                           
                                                         2,58                              Rothenberg CellLine \[38\]                                     

  VMRC-LCD                                               2,67\                             CCLE \[31\]\                                                   
                                                         2,57                              Rothenberg CellLine \[38\]                                     

  LU65A                                                  2,75                              Rothenberg CellLine \[38\]                                     

  Large cell lung carcinoma                              Calu-6                            2,59                           Lu lung \[67\]                  

  Giant cell lung carcinoma                              LU65B                             3,03                           Rothenberg CellLine \[38\]      

  Small cell lung carcinoma                              NCI-H510                          2,83                           CCLE \[31\]                     

  DMS53                                                  2,69                              Olejniczak CellLine 2 \[68\]                                   

  SBC-5                                                  2,69\                             CCLE \[31\]\                                                   
                                                         2,64                              Rothenberg CellLine \[38\]                                     

  DMS114                                                 2,55                              CCLE \[31\]                                                    

  Non-small cell lung carcinoma                          NCI-H1581                         2,67                           CCLE \[31\]                     

  Squamous cell lung carcinoma                           HCC1897                           3,53                           CCLE \[31\]                     

  NCI-HI703                                              2,63\                             CCLE \[31\]\                                                   
                                                         2,61                              Wooster CellLine \[N/A\]                                       

  Lung carcinoma                                         EPLC272H                          2,56                           CCLE \[31\]                     

  Lymphoid tissue                                        Anaplastic large cell lymphoma    Ki-JK                          3,21\                           CCLE \[31\]\
                                                                                                                          2,80                            Barretina CellLine 2 \[31\]

  Non-Hodking B cell Lymphoma                            JM1                               2,79                           CCLE \[31\]                     

  Non-Hodking T cell Lymphoma                            SR786                             2,78                           CCLE \[31\]                     

  SUDHL1                                                 2,65                              CCLE \[31\]                                                    

  Splenic marginal zone B-cell lymphoma                  SLVL                              2,63                           Rothenberg CellLine \[38\]      

  Ovarian                                                Ovarian adenocarcinoma            TOV21G                         2,98                            CCLE \[31\]

  OVK18                                                  2,89                              CCLE \[31\]                                                    

  CAO V3                                                 2,62                              CCLE \[31\]                                                    

  Ovarian clear cell adenocarcinoma                      OVTOKO                            4,04\                          CCLE \[31\]\                    
                                                                                           3,20                           Barretina CellLine 2 \[31\]     

  Ovarian mucinous custadenocarcinoma                    MCAS                              3,05\                          CCLE \[31\]\                    
                                                                                           2,92\                          Rothenberg CellLine \[38\]\     
                                                                                           2,68                           Barretina CellLine 2 \[31\]     

  Ovarian carcinoma                                      OVSAHO                            2,72                           CCLE \[31\]                     

  Ovarian carcinoma                                      OVK12                             2,65                           Barretina CellLine 2 \[31\]     

  Ovarian granulosa cell tumor                           COV434                            2,80                           CCLE \[31\]                     

  Pancreas                                               Ampulla of Vater adenocarcinoma   SNU-478                        3,08                            Barretina CellLine 2 \[31\]

  Pancreatic adenocarcinoma                              PSN1                              2,75\                          CCLE \[31\]\                    
                                                                                           2,61                           Barretina CellLine 2 \[31\]     

  PANC1                                                  2,64\                             CCLE \[31\]\                                                   
                                                         2,53                              Barretina CellLine2 \[31\]                                     

  PK1                                                    2,53                              CCLE \[31\]                                                    

  Panreatic carcinoma                                    PK45H                             2,63                           CCLE \[31\]                     

  YAPC                                                   2,62                              CCLE \[31\]                                                    

  Skin                                                   Cutaneous melanoma                A7                             2,81                            Wooster CellLine \[N/A\]

  Melanoma                                               IGR1                              2,63                           CCLE \[31\]                     

  Squamous cell adenocarcinoma                           HCC95                             2,78                           Sos CellLine \[69\]             

  HCC-15                                                 2,59                              Sos CellLine \[69\]                                            

  Thyroid                                                Follicular thyroid carcinoma      ML1                            2,53                            CCLE \[31\]
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

N/A indicating not available

There are errors in [Table 2](#pone.0141036.t001){ref-type="table"} and in its caption. Please see the corrected [Table 2](#pone.0141036.t001){ref-type="table"} and its correct caption below.

There are errors in the last sentence in the penultimate paragraph of the Discussion. It should read: Interestingly, searching in the Oncomine cancer genomics database and Cancer Cell Line Encyclopedia, CCLE, revealed a duplication in *Usmg5* copy number in various cancer cell lines ([Table 2](#pone.0141036.t001){ref-type="table"}), highlighting several lung, gastric, ovarian, liver and pancreatic cancer cell lines by supporting fidelity in duplication. The copy number was also confirmed in some breast, endometrial, esophageal, hematopoietic, kidney and lymphoid cell lines. Despite the link between DAPIT and the tumorigenic capacity has not been sufficiently demonstrated, this result strengthens a correlative involvement of DAPIT in cancer and suggests a possible oncogenic function for it.
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